Riverstone Holdings (SGX:AP4
) has reported a net profit of RM207.8 mil for FY2025, ended Dec 31, 2025, down 27.6% y-o-y. For 4QFY2025, net profit came in 23.0% y-o-y lower at RM54.0 million.
Revenue for 4QFY2025 improved 1.3% q-o-q to RM250.7 million, driven by cleanroom demand as a result of continued expansion in data centre and AI-related industries. The company also witnessed a slight increase in sales volume for its healthcare segment.
Despite the positivity, revenue for FY2025 declined by 7.2% y-o-y to RM995.3 million, impacted by lower average selling prices (ASP) of generic healthcare gloves due to intensified competition as well as foreign exchange translation losses arising from the rapid strengthening of the Malaysian ringgit against the US dollar.
Gross profit for 4QFY2025 eased 3.0% q-o-q to RM74.2 million, with gross profit margin easing by 1.3 percentage points (ppts) to 29.6%, largely due to the foreign exchange losses.
Riverstone’s board has recommended a final dividend of 5.0 sens per ordinary share, which is subject to shareholders’ approval in the forthcoming annual general meeting, and a special interim dividend of 4.0 sens per ordinary share.
Including the 8.0 sens dividend distributed over the past three quarters, total dividend for FY2025 amounts to 17.0 sens, which translates to a dividend payout ratio of 121.3%.
See also: Food Empire marks 25th year as a listco with 'best performance ever'
“As the Group continues to shift its focus away from low-margin generic volumes towards its core cleanroom and customised healthcare segments, and with raw material costs expected to normalise from 2QFY2026, we remain confident in the long-term resilience of our business,” says Wong Teek Son, Riverstone’s executive chairman and CEO.
Shares in Riverstone Holdings closed 2 cents lower or 2.45% down at 79.5 cents on Feb 25.
